Alternative Name: Ulipristal acetate (UPA) Oral

Description: An estrogen-free, daily low dose oral of a selective progesterone receptor modulator, ulipristal acetate (UPA).

Product Details

User: Female

Hormonal: Yes

Delivery Method: Oral

Duration Type: Short-acting

Duration: One day

  • daily

Dose: 10 mg

Active Pharmaceutical Ingredient (API):
  • ulipristal acetate

Multipurpose Preventive Technology (MPT): No

Status Details

Developer: HRA Pharma, NICHD

Project Phase: Pre-Clinical and Clinical Development

Development Stage: Phase II

Active Development: Yes

Status Details:
  • A phase II clinical trial to assess efficacy, safety, and acceptability is ongoing under the auspices of the NICHD Contraceptive Clinical Trials Network.

Additional Information


Vertical Tabs